Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × artenimol × Clear all

Phase

Phase 2 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 47 Dexamethasone 47 Cyclophosphamide 37 Saline Solution 35 Cytarabine 34 Sodium Chloride 29 Cisplatin 29 Zoledronic Acid 28 Letrozole 28 Bupivacaine 28 Propofol 26 Carboplatin 26 Docetaxel 25 Dexmedetomidine 25 Bevacizumab 25 Vincristine 24 Methotrexate 24 Fentanyl 24 Fluorouracil 23 Capecitabine 22 Doxorubicin 21 Rituximab 20 Paclitaxel 19 Morphine 19 Prednisone 18 Oxaliplatin 18 Drug Therapy 18 Acetaminophen 18 Imiquimod 17 Imatinib Mesylate 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05465135 2024-05-17

The Effect of Dihydroartemisinin in PCOS

Shanghai Zhongshan Hospital

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡